Citadel Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,600
| Closed | -$56.8K | – | 15991 |
|
|
2024
Q4 | $56.8K | Sell |
4,600
-103,600
| -96% | -$1.19M | ﹤0.01% | 12250 |
|
|
2024
Q3 | $1.23M | Sell |
108,200
-1,900
| -2% | -$19.1K | ﹤0.01% | 6436 |
|
|
2024
Q2 | $786K | Buy |
110,100
+8,800
| +9% | +$67.3K | ﹤0.01% | 7082 |
|
|
2024
Q1 | $679K | Buy |
101,300
+88,700
| +704% | +$610K | ﹤0.01% | 7729 |
|
|
2023
Q4 | $81.9K | Buy |
12,600
+7,800
| +163% | +$50.3K | ﹤0.01% | 11192 |
|
|
2023
Q3 | $45.3K | Sell |
4,800
-13,700
| -74% | -$165K | ﹤0.01% | 11858 |
|
|
2023
Q2 | $258K | Sell |
18,500
-3,600
| -16% | -$61.4K | ﹤0.01% | 9344 |
|
|
2023
Q1 | $415K | Buy |
22,100
+9,900
| +81% | +$163K | ﹤0.01% | 8693 |
|
|
2022
Q4 | $168K | Buy |
+12,200
| New | +$187K | ﹤0.01% | 10428 |
|
|
2022
Q1 | – | Sell |
-10,500
| Closed | -$306K | – | 14785 |
|
|
2021
Q4 | $306K | Buy |
+10,500
| New | +$300K | ﹤0.01% | 10876 |
|
|
2020
Q4 | – | Sell |
-20,700
| Closed | -$158K | – | 11650 |
|
|
2020
Q3 | $158K | Buy |
20,700
+10,200
| +97% | +$77.2K | ﹤0.01% | 8965 |
|
|
2020
Q2 | $69K | Buy |
+10,500
| New | +$58.6K | ﹤0.01% | 9167 |
|
|
2018
Q4 | – | Sell |
-39,000
| Closed | -$268K | – | 9883 |
|
|
2018
Q3 | $268K | Buy |
39,000
+3,600
| +10% | +$21.3K | ﹤0.01% | 7760 |
|
|
2018
Q2 | $139K | Buy |
+35,400
| New | +$123K | ﹤0.01% | 8108 |
|
|
2017
Q3 | – | Sell |
-1,757
| Closed | -$7K | – | 8156 |
|
|
2017
Q2 | $7K | Sell |
1,757
-2,029
| -54% | -$8.31K | ﹤0.01% | 7385 |
|
|
2017
Q1 | $17K | Buy |
3,786
+2,329
| +160% | +$7.8K | ﹤0.01% | 7293 |
|
|
2016
Q4 | $3K | Buy |
+1,457
| New | +$3.41K | ﹤0.01% | 7169 |
|
|
2016
Q2 | – | Sell |
-1,800
| Closed | -$5K | – | 7520 |
|
|
2016
Q1 | $5K | Buy |
1,800
+1,671
| +1,295% | +$8.94K | ﹤0.01% | 6627 |
|
|
2015
Q4 | $1K | Sell |
129
-185
| -59% | -$1.49K | ﹤0.01% | 8627 |
|
|
2015
Q3 | $2K | Buy |
314
+57
| +22% | +$476 | ﹤0.01% | 8747 |
|
|
2015
Q2 | $2K | Sell |
257
-86
| -25% | -$827 | ﹤0.01% | 8628 |
|
|
2015
Q1 | $3K | Buy |
343
+14
| +4% | +$135 | ﹤0.01% | 8391 |
|
|
2014
Q4 | $3K | Sell |
329
-457
| -58% | -$4.6K | ﹤0.01% | 8341 |
|
|
2014
Q3 | $7K | Buy |
786
+743
| +1,728% | +$8.32K | ﹤0.01% | 7846 |
|
|
2014
Q2 | $1K | Sell |
43
-1,614
| -97% | -$20.4K | ﹤0.01% | 7896 |
|
|
2014
Q1 | $22K | Buy |
1,657
+1,528
| +1,184% | +$20.1K | ﹤0.01% | 7248 |
|
|
2013
Q4 | $1K | Sell |
129
-485
| -79% | -$4.56K | ﹤0.01% | 6943 |
|
|
2013
Q3 | $6K | Sell |
614
-6,786
| -92% | -$67.4K | ﹤0.01% | 6567 |
|
|
2013
Q2 | $67K | Buy |
+7,400
| New | +$77.6K | ﹤0.01% | 5494 |
|
Other funds holding CDMO
Citadel Advisors's CDMO Position: Q1 2025 in Review
Citadel Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 95,780 shares — an estimated $1.18M sold.
Citadel Advisors first reported a position in CDMO in Q2 2013 and held it in 38 quarters. The position peaked at $13.4M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Citadel Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Citadel Advisors sold 95,780 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.18M.
- Citadel Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
- Citadel Advisors's Avid Bioservices, Inc. Common Stock position peaked at $13.4M in Q3 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.